Avience Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 01-07-2024
- Paid Up Capital ₹ 3.28 Cr
as on 01-07-2024
- Company Age 5 Year, 27 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.97 Cr
as on 01-07-2024
- Satisfied Charges ₹ 2.62 Cr
as on 01-07-2024
- Revenue 7.73%
(FY 2023)
- Profit 8.86%
(FY 2023)
- Ebitda 16.99%
(FY 2023)
- Net Worth 45.69%
(FY 2023)
- Total Assets 64.36%
(FY 2023)
About Avience Biomedicals
The Company is engaged in the Life Science Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 3.28 Cr.
The company currently has active open charges totaling ₹6.97 Cr. The company has closed loans amounting to ₹2.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Janardan Pal, Ram Choudhary, and Dharam Choudhary serve as directors at the Company.
- CIN/LLPIN
U74999DL2019PTC359158
- Company No.
359158
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Avience Biomedicals Private Limited offer?
Avience Biomedicals Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Biochemistry Analyzer, IVDs & Analyzers, Plastic & Glass Labware, Laboratory Plasticware.
Who are the key members and board of directors at Avience Biomedicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharam Choudhary  | Managing Director | 23-Dec-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Janardan Pal | Director | 23-Dec-2019 | Current |
| Ram Choudhary | Director | 23-Dec-2019 | Current |
Financial Performance of Avience Biomedicals.
Avience Biomedicals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.73% increase. The company also saw a slight improvement in profitability, with a 8.86% increase in profit. The company's net worth Soared by an impressive increase of 45.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avience Biomedicals?
In 2023, Avience Biomedicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Dr Meditech Surgical And Diagnostics (India) Private LimitedActive 14 years 10 monthsJanardan Pal, Ram Choudhary and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 23 Jan 2023 | ₹3.43 Cr | Open |
Bank Of India Creation Date: 23 Jan 2023 | ₹1.70 M | Open |
Bank Of India Creation Date: 23 Jan 2023 | ₹3.37 Cr | Open |
How Many Employees Work at Avience Biomedicals?
Unlock and access historical data on people associated with Avience Biomedicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avience Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avience Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
